Search results
Bio-Sourcing and Afrigen Biologics partner on biomanufacturing platform
Medical Device Network via Yahoo Finance· 3 days agoBelgian biotech, Bio-Sourcing, and Cape Town based company, Afrigen Biologics, have signed a...
Here are Thursday's biggest analyst calls: Apple, Nvidia, Tesla, Netflix, Alphabet, United,...
CNBC· 2 days agoHere are the biggest calls on Wall Street on Thursday: Morgan Stanley reiterates Tesla as overweight...
What’s wrong with your brain? It could come down to what you need more of each night
Miami Herald via Yahoo News· 2 days ago“There is no cure for Alzheimer’s disease, but it is a new era of treatment,” said Curiel Cid. The...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 4 days agoIn May 2024, AstraZeneca signed a global licence and option agreement with Nona Biosciences for a...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoSAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will participate in a Fireside Chat at Goldman Sachs 45th Annual Global Healthcare Conference to be held
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
The Woonsocket Call· 4 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on June 1, 2024 the Company granted ...
The Push to Get More People Into Long COVID Studies
Medscape· 4 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab
MedPage Today· 5 days agoConsolidation treatment with durvalumab (Imfinzi) following concurrent chemoradiotherapy...
After key rare disease win, Annexon eyes $144 million raise - San Francisco Business Times
The Business Journals· 2 days agoAnnexon Inc. hopes to sell $125 million of stock following a late-stage clinical trial of a drug...
Fauci faces skeptical GOP to bat back COVID-19 accusations - Roll Call
CQ Politics· 4 days agoLongtime government scientist Anthony Fauci pushed back against Republican accusations tying him to...
